Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Change in Accured Expenses (2019 - 2026)

Updated

Celularity's Change in Accured Expenses was -$1.68 million in Q1 2026, compared with $2.71 million a year earlier.

Analysis

Celularity (CELU) Change in Accured Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Celularity's Change in Accured Expenses was $9.07 million through Mar 31, 2026, down 36.0% year-over-year; for FY2025, it came in at $13.45 million, up 6.5% from FY2024.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 135.9% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $12.63 million in FY2024, -$1.13 million in FY2023, -$2.62 million in FY2022 and -$1.8 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Change in Accured Expenses since Q4 2023.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last five quarters, with growth averaging 118.5%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2024 (growth of 359.2%); the worst was Q3 2025 (a decline of 79.8%).
  • Per Business Quant data, CELU's Change in Accured Expenses in the three quarters before Q1 2026 was $3.7 million (Q4 2025), $822,000 (Q3 2025) and $6.23 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Celularity 40.27 Mn 32.74 Mn 2.39 Mn -1.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.68 Mn
Dec 31, 2025 3.70 Mn
Sep 30, 2025 822,000.00
Jun 30, 2025 6.23 Mn
Mar 31, 2025 2.71 Mn
Dec 31, 2024 5.40 Mn
Sep 30, 2024 4.08 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 -2.66 Mn
Sep 30, 2023 888,000.00
Jun 30, 2023 -84,000.00
Mar 31, 2023 729,000.00
Dec 31, 2022 -9.17 Mn
Sep 30, 2022 795,000.00
Jun 30, 2022 5.15 Mn
Mar 31, 2022 604,000.00
Dec 31, 2021 -5.65 Mn
Sep 30, 2021 2.62 Mn
Jun 30, 2021 2.50 Mn
API Access

Celularity Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEY